OBJECTIVE: The present work aimed to investigate how the Ca(2+)-dependent cell adhesion molecule vascular endothelial (VE)-cadherin might be involved in atherogenesis. METHODS: Specimens of human carotid artery and aorta were obtained at operation. An immunohistochemical approach using cell-type specific antibodies examined how VE-cadherin expression in areas of neovascularisation related to the accumulation of immunocompetent and inflammatory cells within atherosclerotic plaque. Electron microscopy was used to examine the structural characteristics of neovessels and the cell composition in the surrounding intimal matrix. RESULTS: In all the non-atherosclerotic aortic segments, VE-cadherin expression was observed only in the adventitia and the outer third of the media. Within the atherosclerotic arterial segments, VE-cadherin was expressed in all layers of the arterial wall including the intima where VE-cadherin was expressed by endothelial cells in areas of neovascularization. In some neovessels, loss of VE-cadherin expression was associated with increased focal accumulation of T-cells, macrophages and dendritic cells. Electron-microscopic examination demonstrated varying degrees of endothelial continuity in the intimal neovessels. Within those neovessels which were surrounded by a large number of immunocompetent and inflammatory cells, some inter-endothelial cell contacts were open allowing the penetration of blood cells through patent intercellular zones. CONCLUSIONS: VE-cadherin is expressed in atherosclerotic lesions by endothelial cells associated with neovascularisation. Downregulation of VE-cadherin expression within some intimal neovessels is accompanied by increased entry of immunocompetent cells into the intimal matrix surrounding areas of neovascularization which suggests that disorganizing endothelial cell-to-cell interactions within neovessels is significant in atherogenesis.
OBJECTIVE: The present work aimed to investigate how the Ca(2+)-dependent cell adhesion molecule vascular endothelial (VE)-cadherin might be involved in atherogenesis. METHODS: Specimens of human carotid artery and aorta were obtained at operation. An immunohistochemical approach using cell-type specific antibodies examined how VE-cadherin expression in areas of neovascularisation related to the accumulation of immunocompetent and inflammatory cells within atherosclerotic plaque. Electron microscopy was used to examine the structural characteristics of neovessels and the cell composition in the surrounding intimal matrix. RESULTS: In all the non-atherosclerotic aortic segments, VE-cadherin expression was observed only in the adventitia and the outer third of the media. Within the atherosclerotic arterial segments, VE-cadherin was expressed in all layers of the arterial wall including the intima where VE-cadherin was expressed by endothelial cells in areas of neovascularization. In some neovessels, loss of VE-cadherin expression was associated with increased focal accumulation of T-cells, macrophages and dendritic cells. Electron-microscopic examination demonstrated varying degrees of endothelial continuity in the intimal neovessels. Within those neovessels which were surrounded by a large number of immunocompetent and inflammatory cells, some inter-endothelial cell contacts were open allowing the penetration of blood cells through patent intercellular zones. CONCLUSIONS:VE-cadherin is expressed in atherosclerotic lesions by endothelial cells associated with neovascularisation. Downregulation of VE-cadherin expression within some intimal neovessels is accompanied by increased entry of immunocompetent cells into the intimal matrix surrounding areas of neovascularization which suggests that disorganizing endothelial cell-to-cell interactions within neovessels is significant in atherogenesis.
Authors: Jamal S Lewis; Natalia V Dolgova; Thomas J Chancellor; Abhinav P Acharya; Jerome V Karpiak; Tanmay P Lele; Benjamin G Keselowsky Journal: Biomaterials Date: 2013-09-03 Impact factor: 12.479
Authors: Gretchen L Bentz; Marta Jarquin-Pardo; Gary Chan; M Shane Smith; Christian Sinzger; Andrew D Yurochko Journal: J Virol Date: 2006-09-20 Impact factor: 5.103
Authors: Judith C Sluimer; Frank D Kolodgie; Ann P J J Bijnens; Kimberly Maxfield; Erica Pacheco; Bob Kutys; Hans Duimel; Peter M Frederik; Victor W M van Hinsbergh; Renu Virmani; Mat J A P Daemen Journal: J Am Coll Cardiol Date: 2009-04-28 Impact factor: 24.094
Authors: Liang Guo; Hirokuni Akahori; Emanuel Harari; Samantha L Smith; Rohini Polavarapu; Vinit Karmali; Fumiyuki Otsuka; Rachel L Gannon; Ryan E Braumann; Megan H Dickinson; Anuj Gupta; Audrey L Jenkins; Michael J Lipinski; Johoon Kim; Peter Chhour; Paul S de Vries; Hiroyuki Jinnouchi; Robert Kutys; Hiroyoshi Mori; Matthew D Kutyna; Sho Torii; Atsushi Sakamoto; Cheol Ung Choi; Qi Cheng; Megan L Grove; Mariem A Sawan; Yin Zhang; Yihai Cao; Frank D Kolodgie; David P Cormode; Dan E Arking; Eric Boerwinkle; Alanna C Morrison; Jeanette Erdmann; Nona Sotoodehnia; Renu Virmani; Aloke V Finn Journal: J Clin Invest Date: 2018-02-19 Impact factor: 14.808
Authors: Seraina Cooksley-Decasper; Hans Reiser; Daniela S Thommen; Barbara Biedermann; Michel Neidhart; Joanna Gawinecka; Gieri Cathomas; Fabian C Franzeck; Christophe Wyss; Roland Klingenberg; Paolo Nanni; Bernd Roschitzki; Christian Matter; Petra Wolint; Maximilian Y Emmert; Marc Husmann; Beatrice Amann-Vesti; Wilibald Maier; Steffen Gay; Thomas F Lüscher; Arnold von Eckardstein; Danielle Hof Journal: PLoS One Date: 2012-10-24 Impact factor: 3.240
Authors: Julia Doulgere; Benjamin Otto; Maher Nassour; Gerrit Wolters-Eisfeld; Holger Rohde; Tim Magnus; Christoph Wagener; Thomas Streichert Journal: BMJ Open Date: 2015-03-10 Impact factor: 2.692